Botulinum toxin A (Revance Therapeutics)

Product Name :
Botulinum toxin A (Revance Therapeutics)

Search keywords :
SNAP25

drugId :
null

Target Vo:
Synaptosomal-associated protein 25

Target Vo Short Name :
SNAP-25

Moa_Name:
Synaptosomal-associated protein 25 inhibitors

First Approval Country :
United States

First Approval Date Filter:
2022

Origin Company_Name :
Revance Therapeutics Inc

Active Company_Name :
Assiut University

Active Indication_Name:
Dystonia

In Active Indication_Name:
Torticollis

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
NDA/BLA

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
F4/80 Antibody
AGEs Antibody
Fatty Acid Synthase Antibody (YA766): Fatty Acid Synthase Antibody (YA766) is a non-conjugated and Mouse origined monoclonal antibody about 273 kDa, targeting to Fatty Acid Synthase (2F9). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat, Monkey.

Author: Betaine hydrochloride

Related Posts